Enhance

The Trouble With Merck: One Analyst Turns Sour

29 Comments

Congress Miffed Over Vytorin Report & Consultant

4 Comments

The Vytorin Limbo: Going Just A Little Lower

6 Comments

Vytorin Update: Preliminary Study Results Today

15 Comments

The Vytorin Limbo: Prescriptions Keep Falling

4 Comments

Will The SEAS Trial Vindicate Vytorin?

13 Comments

Does A Lipitor Study Give Vytorin A Boost?

17 Comments

The Road To Hell Is Paved With Biological Plausibility

12 Comments

Merck And Schering-Plough End A Joint Venture

1 Comment

Look, Ma, No Vytorin! John McCain Switched Meds

30 Comments

Clear

Clear

© 2007- 2008 Newark Morning Ledger Co.  All Rights Reserved.

Thanks for trying out the new Pharmalot printing tools. If you're got any suggestions for how we can help you print better, please let us know by clicking on the contact link at http://www.pharmalot.com/